Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The company has informed BSE that its Board of Directors will meet on Friday, 14 November 2025 at the registered office in Jaipur. The main agenda is to approve the IND-AS compliant standalone unaudited financial results along with the Limited Review Report for the quarter and half year ended 30 September 2025, under Regulation 33 of SEBI LODR. Any other matter with the Chair's permission may also be taken up. The trading window for dealing in the company's shares has already been closed since 1 October 2025 and will reopen 48 hours after the results are announced to the stock exchange.
This is a routine procedural filing ahead of the Q2 FY26 results announcement and does not contain any financial details. Shareholders should watch for the actual results on or after 14 November 2025, as the numbers could move the stock once the trading window reopens.